Table of Contents
Successful cord blood stem cell transplantation requires meeting several medical requirements. One of the most crucial conditions is the compatibility of the donor and the recipient. Before the transplantation occurs, the physicians need to assess whether the stem cells will function safely in the patient’s body after transplantation. This is, in fact, the realm of HLA typing.
While blood type may be the first thing that comes to mind when people think about stem cell transplants, it is not the deciding factor in finding a suitable donor. Although blood type is an important consideration, it is not the primary criterion. Instead, doctors evaluate several protein markers that help the immune system recognise the body’s own cells and distinguish them from foreign cells.
What Is HLA Typing?
HLA typing is a laboratory test used to identify genetic markers called Human Leukocyte Antigens (HLA), which are present on the surface of most cells in the body. The immune system continually monitors these membrane proteins to see if the cells are the body’s own or whether they are foreign. A stem cell has a better chance of integrating successfully when its HLA markers closely match the patient’s.
Nowadays, laboratories test multiple HLA genes to build a comprehensive compatibility profile then transmitted to the transplant team, which compares these different samples to the recipient.
Why HLA Typing Matters Before a Stem Cell Transplant
A common question is why we need to perform HLA typing before a stem cell transplant.
The answer lies in the body’s natural immune defence. Although transplanted stem cells are intended to restore healthy blood-forming cells, the recipient’s immune system may recognise them as foreign if their HLA markers differ significantly. Having a close match of HLA proteins reduces the risk of complications such as:
- Graft rejection: The recipient’s body attacks the transplanted cells.
- Graft-versus-host disease (GVHD): A condition where the donor’s immune cells target the healthy tissue of the new host.
- Delayed or failed engraftment: The new cells take too long to grow or do not grow at all.
- Higher likelihood of infection during the healing process.
Routine compatibility screening can help clinicians select a donor source that offers the best chance of successful transplantation and fewer potential complications.
How Does HLA Matching Work?
Before a stem cell transplant can proceed, a sample of blood or a cheek swab is taken from the patient. A lab that performs HLA typing analyses the sample.
Potential donor samples undergo the same testing process. Specialists examine HLA markers at several locations in the genes (called HLA loci) to determine the degree of matching between the donor and recipient.
Almost all types of transplant procedures require finding a good match between the donor and the recipient. The required level of matching, however, depends on the source of the stem cells.
Several factors influence donor selection, including:
- The level of HLA matching.
- The diagnosis and treatment requirements of the patient.
- The number and quality of stem cells being sourced.
- The urgency of the transplant.
This comprehensive research aids transplant teams in choosing a donor to provide the best chance for successful engraftment.
Is HLA Matching Different for Cord Blood?
Cord blood has several biological characteristics that distinguish it from other stem cell sources.
The immune cells in cord blood are immature and typically more adaptable than those from adult donors. Therefore, a perfect match at the HLA loci is not always required. Sometimes, cord blood can still be a good choice for a transplant even if there is some mismatch in HLA.
Even so, compatibility remains a key factor in deciding on a donor. Doctors do a thorough analysis of the HLA match and the cell dose within the cord blood unit before recommending it.
Doctors always take an individualised approach to each transplant, considering the patient’s age, overall status, and disease activity.
What Happens If an Ideal Match Is Not Found?
It can be difficult to find a fully compatible donor, especially for recipients of non-Caucasian ethnicity or those of mixed ancestry.
Thanks to progress in transplant medicine, a wider choice of treatment options is available. Doctors can potentially use cord blood units with an acceptable matching status, other family donors, or other carefully studied donor sources.
Transplant professionals examine several clinical factors beyond HLA matching before advising to proceed with transplantation. They aim to optimise transplant results and maintain the right balance between risks and benefits.
The Role of HLA Typing in Personalised Transplant Care
Each patient’s immune profile is unique; therefore, there is no shortcut when selecting a donor.
Before a stem cell transplant, HLA typing provides healthcare providers with the patient’s genetic match information. This data, when used alongside clinical assessments and other laboratory tests, allows physicians to make informed clinical decisions to treat the patient best.
By being so thorough, this process has become an integral part of modern medicine, guiding clinicians in selecting an appropriate donor source to help achieve successful transplant outcomes.
Final Thoughts
HLA typing is incredibly important before a stem cell transplant. It is a crucial step in estimating the compatibility between the stem cell donor and the recipient. While more affordable cord blood options may make storage easier, compatibility remains a key factor in choosing an appropriate donor.
Knowing the reason for HLA typing helps the patient and their family realise why transplant specialists dedicate considerable time to assessing potential donor candidates before treatment can proceed. This comprehensive assessment allows for a safer transplant, minimises the risk of immune complications, and maximises the chance of a successful recovery.